What You Need to Know
Pfizer Inc. (PFE), headquartered in New York, discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products. With a…
Johnson & Johnson halts mid-stage trial of experimental eczema drug
Johnson & Johnson offices in Irvine, California, US, on Friday, Oct. 10, 2025. Kyle Grillot | Bloomberg |…
Pfizer 2026 guidance shows Metsera, Seagen deals will take time to pay off
Smith Collection | Archive Photos | Getty Images Pfizer on Tuesday forecast modest 2026 guidance as it looks…
FDA Pulls Warning Labels From Hormone Replacement Therapies
Hormone replacement therapies used to treat menopause symptoms no longer need to carry strict warnings about some potential…
Metsera Weight-Loss Drug Shows ‘Excellent’ Tolerability in Study
Metsera Inc.’s next-generation weight-loss drug showed good tolerability with few participants dropping out of a mid-stage trial, adding…
Lilly, Novo to Lower Obesity Drug Prices in Deal with Trump
Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for…
Metsera calls Novo Nordisk’s new bid superior to Pfizer offer
The logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy…
Pfizer files second lawsuit against Novo Nordisk, Metsera
A Pfizer logo is displayed at a research facility in the La Jolla neighborhood of San Diego, California,…
Pfizer sues Metsera, Novo Nordisk over rival obesity drug bid
Thomas Fuller | SOPA Images | Lightrocket | Getty Images Pfizer said on Friday it had filed a lawsuit against Metsera and Novo…
Why an Old Multiple Sclerosis Drug Costs More Than Ever in the US
When Jean Kay started a brand-new multiple sclerosis treatment called Rebif in 2003, it cost $17,500 a year.…
Pfizer’s Q3 2025 Earnings: What to Expect
With a market cap of $139.4 billion, Pfizer Inc. (PFE) is a global biopharmaceutical company headquartered in New York, known…
New ALS Research Backs Trailblazer’s Focus on Immune System
Hi, it’s Jason in Melbourne. A study in Nature last week shows the immune system itself may be…